VETTORE LLC has a total of 26 patent applications. It decreased the IP activity by 70.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and Israel. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GLIAPHARM SA, NOCION THERAPEUTICS INC and C4 THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 3 | |
#3 | Israel | 3 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Republic of Korea | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 | |
#10 | Hong Kong | 1 | |
#11 | Mexico | 1 | |
#12 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Parnell Kenneth Mark | 18 |
#2 | Mccall John M | 13 |
#3 | Romero Donna | 9 |
#4 | Mccall John | 7 |
#5 | John M Mccall | 3 |
#6 | Kenneth Mark Parnell | 2 |
#7 | Parnell Kenneth | 2 |
#8 | Donna Romero | 2 |
#9 | Mark Kenneth Parnell | 1 |
Publication | Filing date | Title |
---|---|---|
MX2019006893A | Heterocyclic inhibitors of mct4. | |
AU2016277126A1 | MCT4 inhibitors for treating disease |